Azelis, the reference innovation service provider in the speciality chemicals and food ingredients industry, is pleased to announce that it has acquired 100% of the shares of Solchem Nature S.L. (‘Solchem’), reinforcing its presence in the Spanish nutraceuticals market.

Customers in Europe will have access to a broad portfolio of innovative and sustainable nutraceutical solutions, leveraging the combined expertise of Azelis and Solchem’s experienced teams.
Principals will see a broader distribution of their products, thanks to Solchem’s greater reach of over 250 customers in the nutraceutical market.
The acquisition aligns with Azelis’s strategy as it focusses on a targeted business that supports growing its market share in Spain, adding expertise to its EMEA-wide nutraceutical platform.

Based in Barcelona, Solchem was founded in 1994 to distribute raw materials for the dietary sector. The company later expanded its portfolio to include a wide range of premium ingredients and formulations for the nutraceutical market.

With a team of 14 staff members, Solchem brings an extensive nutraceutical portfolio to the Iberian market. Backed by long-standing relationships with well-known principals in the industry, it is a valuable contribution to Azelis’s lateral value chain. The acquisition presents principals with new opportunities for growth and customers with a wider range of products to innovate with.

Jose Manuel González, General Manager at Solchem Nature, comments:
“Joining forces with Azelis is not only an exciting growth opportunity for Solchem, but also a natural fit. We share a strong innovation-driven culture, rooted in a commitment to excellence towards our principals and customers. We look forward to continuing our journey with Azelis to deliver the best solutions to our partners in the nutraceutical market.”

Javier Pérez, Managing Director at Azelis Iberia, adds:
“We are excited to welcome Solchem to the Azelis team. Our combined capabilities significantly strengthen Azelis’s position in the highly attractive nutraceutical market. With common values and the same entrepreneurial and collaborative spirit, I’m convinced we will successfully continue to unlock the nutraceutical market’s untapped potential together.”

- END -

About Azelis
Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry present in 65 countries across the globe with over 4,300 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to more than 62,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.2 billion (2024). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BEL®ESG indices.

Across our extensive network of more than 70 application and formulating laboratories, our award-winning teams help develop formulations and provide technical guidance throughout the customers’ product development process. We combine a global market reach with a local footprint to offer a reliable, integrated, and unique digital service to local customers and attractive- business opportunities to principals. Top industry-rated by Sustainalytics, Azelis is a leader in sustainability. We believe in building and nurturing solid, honest, and transparent relationships with our people and partners.

Impact through ideas. Innovation through formulation.

www.azelis.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250406325936/en/

Contact information

Azelis
Noémie Bruneau
EMEA Corporate Communications Business Partner
T: +32 478 51 02 23
E: noemie.bruneau@azelis.com

Logo

Tags

More Like This

HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners

Olon Continues its Growth Path and Announces a New Acquisition

ZINZINO AB (PUBL): Zinzino acquires assets in Xeliss - strategic reinforcement in southern Europe and in the microalgae spirulina

SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection

Americhem's Sustainability Journey: Surpassing Milestones and Forging Ahead!

Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals

Lubrizol’s Apisolex™ Polymer Wins Finished Formulation Award at CPhI Barcelona

ELIQUENT Life Sciences Announces Strategic Acquisition of Azzur Consulting – Strengthening Full-Service Quality & Compliance Capabilities